About Neela Therapeutics
Neela Therapeutics is a private company based in Lunenburg, Massachusetts, incorporated in 2025 in Delaware. It has reported $13,821,643 raised in one offering on Form D since November 2025. Its chief executive is David Donabedian.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Nov 24, 2025amended May 26, 2026 | $13,821,643of $21.5M target | 21 | $658K | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Neela Therapeutics's Form D filed May 26, 2026.
RU
Richard Upton
Partner, Harbor Light Capital Partners and director
Also a director at Alcyone Therapeutics and Anuncia Medical.
EJ
NR
DD
David Donabedian
Founding CEO, Newleos Therapeutics and director
Also a director at Alcyone Therapeutics and Anuncia Medical.
Pj Anand
Founder, President and Chief Executive Officer, director
Also a chief executive officer and director at Alcyone Therapeutics and Arthromeda and a director at Anuncia Medical.
SO